ZA877859B - 5-nitrobenzo(de)isoquinoline-1.3-diones,their preparation and their use - Google Patents

5-nitrobenzo(de)isoquinoline-1.3-diones,their preparation and their use

Info

Publication number
ZA877859B
ZA877859B ZA877859A ZA877859A ZA877859B ZA 877859 B ZA877859 B ZA 877859B ZA 877859 A ZA877859 A ZA 877859A ZA 877859 A ZA877859 A ZA 877859A ZA 877859 B ZA877859 B ZA 877859B
Authority
ZA
South Africa
Prior art keywords
nitrobenzo
diones
isoquinoline
preparation
compounds
Prior art date
Application number
ZA877859A
Other languages
English (en)
Inventor
Miguel Brana Fernandez
Brana Fernandez Miguel
Jose Maria Berlanga Castellano
Maria Berlanga Castellano Jose
Marina Moran Moset
Moran Moset Marina
Erich Schlick
Schlick Erich
Gerhard Keilhauer
Keilhauer Gerhard
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA877859B publication Critical patent/ZA877859B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA877859A 1986-10-21 1987-10-20 5-nitrobenzo(de)isoquinoline-1.3-diones,their preparation and their use ZA877859B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863635711 DE3635711A1 (de) 1986-10-21 1986-10-21 5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ZA877859B true ZA877859B (en) 1989-06-28

Family

ID=6312114

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA877859A ZA877859B (en) 1986-10-21 1987-10-20 5-nitrobenzo(de)isoquinoline-1.3-diones,their preparation and their use

Country Status (9)

Country Link
US (1) US5552544A (zh)
EP (1) EP0268093B1 (zh)
JP (1) JPS63104963A (zh)
AT (1) ATE76069T1 (zh)
AU (1) AU592474B2 (zh)
CA (1) CA1331382C (zh)
DE (2) DE3635711A1 (zh)
ES (1) ES2037055T3 (zh)
ZA (1) ZA877859B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939372A1 (de) * 1989-11-29 1991-06-06 Knoll Ag Mitonafide-infusionsloesung
DE3942280A1 (de) * 1989-12-21 1991-06-27 Knoll Ag N-substituierte naphthalimide, ihre herstellung und verwendung
US5235045A (en) * 1992-03-19 1993-08-10 Microbiomed Corporation Non-azo naphthalimide dyes
US5766600A (en) * 1993-08-09 1998-06-16 Microbiomed Corporation Non-azo naphtalimide dyes and uses for same
DK0930883T3 (da) 1996-10-21 2006-05-22 Nps Allelix Corp Neurotrofinantagonister til behandling af epilepsi, Alzheimers sygdom og smerte
DE19714161A1 (de) * 1997-04-05 1998-10-08 Emtec Magnetics Gmbh Magnetischer Aufzeichnungsträger
CZ20011782A3 (cs) * 1998-11-25 2001-09-12 Merck Patent Gmbh Derivát benzo[de]isochinolin-1,3-dionu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US6468990B1 (en) * 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
NZ525730A (en) * 2000-11-06 2004-12-24 Pharma Mar S Compositions for antitumour treatments containing Ecteinascidin 743
DE10101319A1 (de) * 2001-01-09 2002-07-18 Schering Ag Morphometrisches Gewebe- oder Zellpräparat
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
US6693198B2 (en) * 2002-04-22 2004-02-17 Xanthus Life Sciences, Inc. Amonafide salts
US20040082788A1 (en) * 2002-07-08 2004-04-29 Chemgenex Therapeutics, Inc. Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
JP2007511499A (ja) * 2003-11-13 2007-05-10 ファーマ・マール・エス・アー・ウー コンビネーション
US20080255132A1 (en) * 2003-11-14 2008-10-16 Eric Rowinsky Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
JP2007536283A (ja) * 2004-05-05 2007-12-13 ユニバイオスクリーン エス．アー． ナフタルイミド誘導体、それらの製造方法、およびそれらの医薬組成物
JP2008505862A (ja) * 2004-07-09 2008-02-28 ファルマ、マール、ソシエダード、アノニマ 予後分子マーカー
CA2583464A1 (en) * 2004-09-29 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
EP1827500B1 (en) * 2004-10-26 2009-05-06 Pharma Mar S.A., Sociedad Unipersonal Pegylated liposomal doxorubicin in combination with ecteinescidin 743
PL1658848T3 (pl) * 2004-10-29 2007-12-31 Pharma Mar Sa Preparaty zawierające ekteinascydynę i disacharyd
US7947839B2 (en) * 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
CA2622574A1 (en) 2005-09-15 2007-03-22 Painceptor Pharma Corporation Methods of modulating neurotrophin-mediated activity
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CA2651197A1 (en) 2006-05-05 2007-11-15 Unibioscreen S.A. 5-urea substituted naphthalimide derivatives, methods of production and pharmaceutical compositions for treating cancer
CA2703026A1 (en) * 2007-10-19 2009-04-23 Rafael Rosell Costa Prognostic molecular markers for et-743 treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES459497A1 (es) * 1977-06-04 1978-04-16 Made Labor Sa Un metodo para la preparacion industrial de naftalimidas y sus derivados.
DE2944867A1 (de) * 1979-11-07 1981-05-27 Hoechst Ag, 6000 Frankfurt Kationische verbindungen der naphthalimid-reihe, verfahren zu deren herstellung und deren verwendung
EP0125439B1 (en) * 1983-04-01 1990-01-24 Warner-Lambert Company 3,6-disubstituted-1,8-naphthalimides and methods for their production and use
US4614820A (en) * 1983-04-01 1986-09-30 Warner-Lambert Co. 3,6-disubstituted-1,8-naphthalimides
DE3614414A1 (de) * 1986-04-29 1987-11-05 Knoll Ag Neue benzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
US4782064A (en) * 1986-07-21 1988-11-01 American Cyanamid Co. 2-heteroaryl-alkyl-1H-benz[de]-isoquinoline-1,3(2H)-diones

Also Published As

Publication number Publication date
ATE76069T1 (de) 1992-05-15
DE3779053D1 (zh) 1992-06-17
AU7999087A (en) 1988-04-28
ES2037055T3 (es) 1993-06-16
EP0268093A1 (de) 1988-05-25
US5552544A (en) 1996-09-03
CA1331382C (en) 1994-08-09
DE3635711A1 (de) 1988-04-28
AU592474B2 (en) 1990-01-11
JPS63104963A (ja) 1988-05-10
EP0268093B1 (de) 1992-05-13

Similar Documents

Publication Publication Date Title
ZA877859B (en) 5-nitrobenzo(de)isoquinoline-1.3-diones,their preparation and their use
PH24491A (en) Cycloalkanol(1,2-b)indole-sulphonamides
PH25020A (en) 2-benzoylcyclic-1,3-dione derivatives
NZ222162A (en) 1,3-cyclohexanedione derivatives and herbicidal compositions
OA08698A (en) Mocrolide compounds, their preparation and their use.
AU545404B2 (en) 5-heterocyclic-cyclohexane-1,3-diones
AU7212587A (en) Benzo (de) isoquinoline-1,3-diones
NO864306L (no) Fremgangsmaate for fremstilling av 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
FI862343A0 (fi) Foerfarande foer framstaellning av terapeutiskt verkande 1,4-dihydropyridinfoereningar.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
AR242797A1 (es) Procedimiento para la preparacion de derivados de acido 16,17-acetal substituido pregnano-21-oico.
NO863343L (no) Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamino-4-aza-octaner.
NO864695D0 (no) Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler.
GB8624251D0 (en) "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
DE3365427D1 (en) Cyclohexane 1,3-dione derivatives
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
DE3376843D1 (en) Preparation process of an organic pigment on the basis of 4,4',7,7'-tetrachlorothioindigo
NO872624D0 (no) Fremgangsmaate for fremstilling av 3,7-dihydro-3-n-propyl-1h-purin-2,6-dion.
AU7568087A (en) 1,3,5-trithiane derivatives
ES507317A0 (es) Procedimiento para la preparacion de derivados de la hexahi-dro-2,3,3,4,5.6-1h-indol(3,2,1-de)(naftiridina-1,5)
NO864307D0 (no) Fremgangsmaate for fremstilling av 5-heterocycliske-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO862887L (no) Fremgangsmaate for bekjempelse av mikroorganismer.
NO875465D0 (no) Fremgangsmaate for fremstilling av aminoalkanoyl-dibenzo(d,g)(1,3,6)dioxazociner.
NO863045D0 (no) Fremgangsmaate for fremstilling av alkyl-2-karboalkoksy-3,4-dialkoksybenzenkarbamater.